Wordt geladen...
Immunotherapy in glioblastoma: emerging options in precision medicine
Immunotherapy for glioblastoma (GBM) provides a unique opportunity for targeted therapies for each patient, addressing individual variability in genes, tumor biomarkers and clinical profile. As immunotherapy has the potential to specifically target tumor cells with minimal risk to normal tissue, sev...
Bewaard in:
| Gepubliceerd in: | CNS Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Future Medicine Ltd
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4926530/ https://ncbi.nlm.nih.gov/pubmed/27225028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns-2016-0009 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|